Strategies to Manage Antibody Drug Conjugates (ADC) - Related Toxicities in Breast Cancer - Episode 4
Expert Perspectives on the Management of SG-Related Neutropenia
This discussion focuses on strategies to manage neutropenia associated with SG, including the use of prophylactic growth factors and timing of their administration, comparing management approaches between clinicians.
Video content above is prompted by the following:
- Please comment on your management strategy to mitigate neutropenia associated with SG.
- What patient characteristics do you consider when deciding to utilize prophylactic growth factor support vs. utilize GCSF as secondary prophylaxis in your clinical practice?
- What days do you typically administer either pegylated growth factors and/or daily filgrastim?
- Please comment on your management strategy to mitigate neutropenia (any similarities vs. differences)